• We are sorry, but NCBI web applications do not support your browser and may not function properly. More information
Logo of tobcontTobacco ControlCurrent TOCInstructions for authors
Tob Control. Sep 1998; 7(3): 253–261.
PMCID: PMC1763872

Training pharmacists and pharmacy assistants in the stage-of-change model of smoking cessation: a randomised controlled trial in Scotland


OBJECTIVE—To evaluate a training workshop for community pharmacy personnel to improve their counselling in smoking cessation based on the stage-of-change model.
DESIGN—A randomised controlled trial of community pharmacies and pharmacy customers.
SETTING—All 76 non-city community pharmacies registered in Grampian, Scotland, were invited to participate. Sixty-two pharmacies (82%) were recruited.
SUBJECTS—All the intervention pharmacy personnel were invited to attend the training; 40 pharmacists and 54 assistants attended. A total of 492 customers who smoked (224 intervention, 268 controls) were recruited during the 12-month recruitment period (overall recruitment rate 63%).
MAIN OUTCOME MEASURES—The perceptions of customers and pharmacy personnel of the pharmacy support and self-reported smoking cessation rates for the two groups of customers at one, four, and nine months.
RESULTS—The intervention customer respondents were significantly more likely to have discussed stopping smoking with pharmacy personnel, 85% (113) compared with 62% (99) of the controls (p<0.001). The former also rated their discussion more highly; 34% (45) of the intervention customers compared with 16% (25) of the controls rated it as "very useful" (p = 0.048). Assuming non-responders had lapsed, one-month point prevalence of abstinence was claimed by 30% of intervention customers and 24% of controls (p = 0.12); four months' continuous abstinence was claimed by 16% of intervention customers and 11% of controls (p = 0.094); and nine months' continuous abstinence was claimed by 12% of intervention customers and 7% of controls (p = 0.089). These trends in outcome were not affected by potential confounders (sex, age, socioeconomic status, nicotine dependence, and type of nicotine replacement product used) or adjustment for clustering.
CONCLUSIONS—The intervention was associated with increased and more highly rated counselling, and a trend toward higher smoking cessation rates, indicating that community pharmacy personnel have the potential to make a significant contribution to national smoking cessation targets.

Keywords: community pharmacy; health education; smoking cessation

Full Text

The Full Text of this article is available as a PDF (166K).

Selected References

These references are in PubMed. This may not be the complete list of references from this article.
  • Lennox AS, Taylor RJ. Factors associated with outcome in unaided smoking cessation, and a comparison of those who have never tried to stop with those who have. Br J Gen Pract. 1994 Jun;44(383):245–250. [PMC free article] [PubMed]
  • Lichtenstein E, Glasgow RE. Smoking cessation: what have we learned over the past decade? J Consult Clin Psychol. 1992 Aug;60(4):518–527. [PubMed]
  • Eaton G, Webb B. Boundary encroachment: pharmacists in the clinical setting. Sociol Health Illn. 1979 Jun;1(1):69–89. [PubMed]
  • Roberts D. Dispensing by the community pharmacist: an unstoppable decline? J R Coll Gen Pract. 1988 Dec;38(317):563–564. [PMC free article] [PubMed]
  • Rollnick S, Kinnersley P, Stott N. Methods of helping patients with behaviour change. BMJ. 1993 Jul 17;307(6897):188–190. [PMC free article] [PubMed]
  • Prochaska JO, DiClemente CC. Stages and processes of self-change of smoking: toward an integrative model of change. J Consult Clin Psychol. 1983 Jun;51(3):390–395. [PubMed]
  • Prochaska JO, Goldstein MG. Process of smoking cessation. Implications for clinicians. Clin Chest Med. 1991 Dec;12(4):727–735. [PubMed]
  • Velicer WF, Prochaska JO, Bellis JM, DiClemente CC, Rossi JS, Fava JL, Steiger JH. An expert system intervention for smoking cessation. Addict Behav. 1993 May-Jun;18(3):269–290. [PubMed]
  • Effectiveness of a nicotine patch in helping people stop smoking: results of a randomised trial in general practice. Imperial Cancer Research Fund General Practice Research Group. BMJ. 1993 May 15;306(6888):1304–1308. [PMC free article] [PubMed]
  • Goldberg DN, Hoffman AM, Farinha MF, Marder DC, Tinson-Mitchem L, Burton D, Smith EG. Physician delivery of smoking-cessation advice based on the stages-of-change model. Am J Prev Med. 1994 Sep-Oct;10(5):267–274. [PubMed]
  • Stott NC, Rollnick S, Rees MR, Pill RM. Innovation in clinical method: diabetes care and negotiating skills. Fam Pract. 1995 Dec;12(4):413–418. [PubMed]
  • Velicer WF, Prochaska JO, Rossi JS, Snow MG. Assessing outcome in smoking cessation studies. Psychol Bull. 1992 Jan;111(1):23–41. [PubMed]
  • Heatherton TF, Kozlowski LT, Frecker RC, Fagerström KO. The Fagerström Test for Nicotine Dependence: a revision of the Fagerström Tolerance Questionnaire. Br J Addict. 1991 Sep;86(9):1119–1127. [PubMed]
  • Bond CM, Bradley C. Over the counter drugs. The interface between the community pharmacist and patients. BMJ. 1996 Mar 23;312(7033):758–760. [PMC free article] [PubMed]
  • Hickey F. Innovations in prescribing information: Report of the UK Drug Utilisation Research Group regional meeting, King's Conference Centre, University of Aberdeen, Wednesday May 31, 1995. Pharmacoepidemiol Drug Saf. 1996 Jul;5(4):263–267. [PubMed]

Articles from Tobacco Control are provided here courtesy of BMJ Group


Related citations in PubMed

See reviews...See all...

Cited by other articles in PMC

See all...


  • Cited in Books
    Cited in Books
    PubMed Central articles cited in books
  • PubMed
    PubMed citations for these articles

Recent Activity

Your browsing activity is empty.

Activity recording is turned off.

Turn recording back on

See more...